http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190093111-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-382 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 |
| filingDate | 2018-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8676f459edce742de8eed9e8886639a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aceb0794e1c2581bfba4fe7e96a74b3d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f5428911ebfdcb2a987d953094ec010 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82b52e20375c3cf27640ed784be53925 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75458e9e9842674f6e71c0e6835313d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec6f62990029bfa04cf57d878fd1e677 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fd6827911602d83b36a562202a05d38 |
| publicationDate | 2019-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190093111-A |
| titleOfInvention | Inhibitor to RTX toxin synthesis and composition for treatment to Vibrio infection disease |
| abstract | The present invention relates to an RTX toxin production inhibitor and a composition for treating a Vibrio infection infection using the same, wherein N- (4-oxo-4H-thieno [3,4-c] chromen having a structure of Formula 11 found in the present invention -3-yl) -3-phenylprop-2-inamide (N- (4-oxo-4H-thieno [3,4-c] chromen-3-yl) -3-phenylprop-2-ynamide) or its As a derivative, a compound having a structure of formula 12, a compound having structure of formula 13, a compound having structure of formula 14, a compound having structure of formula 15, a compound having structure of formula 16, formula 17 Compound having a structure of, Compound having the structure of formula 21, Compound having the structure of formula 22, Compound having the structure of formula 23, Compound having the structure of formula 24, Compound having the structure of formula 25 , A compound having a structure of Formula 26, a structure of Formula 27 Compound, a compound having a structure of formula 28 and a structure of formula 29, inhibits Vibrio infection by inhibiting the production of RTX toxin, rather than killing Vibrio bacteria directly, Prophylaxis or treatment). Thus, the present invention can be an alternative to antibiotics that are inherently subject to the problem of causing resistance by targeting the killing of the bacteria themselves. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230026767-A |
| priorityDate | 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.